R Kumar Selected Research

R Kumar Research Topics

Disease

61	Neoplasms (Cancer) 01/2021 - 01/2000
35	Breast Neoplasms (Breast Cancer) 04/2018 - 01/2000
18	Infections 07/2020 - 07/2000
10	Neoplasm Metastasis (Metastasis) 03/2014 - 12/2000
9	Body Weight (Weight, Body) 01/2022 - 12/2001
9	Wounds and Injuries (Trauma) 10/2021 - 06/2000
8	Prostatic Neoplasms (Prostate Cancer) 03/2021 - 03/2011
8	Asthma (Bronchial Asthma) 09/2017 - 12/2000
7	Pain (Aches) 01/2022 - 05/2000
7	Vitiligo 01/2019 - 01/2011
7	Hemorrhage 07/2018 - 08/2001
7	Visceral Leishmaniasis (Kala Azar) 12/2014 - 05/2001
7	Melanoma (Melanoma, Malignant) 03/2014 - 05/2000
6	Cysts 03/2006 - 04/2001
5	Shock 02/2022 - 07/2001
5	Inflammation (Inflammations) 10/2020 - 04/2001
5	Tuberculosis (Tuberculoses) 10/2018 - 07/2000
5	Multiple Myeloma 10/2017 - 01/2002
5	Head and Neck Neoplasms (Head and Neck Cancer) 05/2017 - 07/2003
5	Pathologic Constriction (Stenosis) 04/2016 - 11/2005
5	Male Infertility (Male Sterility) 01/2011 - 03/2007
5	Parkinson Disease (Parkinson's Disease) 12/2004 - 01/2000
4	COVID-19 05/2022 - 12/2020
4	Stroke (Strokes) 04/2022 - 01/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 02/2015
4	Obesity 03/2021 - 11/2014
4	Lung Neoplasms (Lung Cancer) 05/2017 - 07/2003
4	Carcinoma (Carcinomatosis) 05/2016 - 01/2008
4	Carcinogenesis 01/2016 - 10/2001
4	Fistula 03/2011 - 03/2003
4	Hyperoxaluria (Oxaluria) 07/2007 - 03/2002
4	Hypertension (High Blood Pressure) 07/2005 - 06/2000
4	Hypersensitivity (Allergy) 07/2005 - 07/2002
4	Colonic Neoplasms (Colon Cancer) 07/2003 - 01/2001
3	Esophageal Neoplasms (Esophageal Cancer) 10/2022 - 07/2003
3	Ulcer 10/2021 - 02/2003
3	Erectile Dysfunction 03/2021 - 10/2006
3	Type 2 Diabetes Mellitus (MODY) 03/2021 - 02/2011
3	Airway Obstruction (Choking) 09/2017 - 08/2014
3	Fibrosis (Cirrhosis) 09/2017 - 10/2003
3	Squamous Cell Carcinoma of Head and Neck 05/2017 - 11/2013
3	Genomic Instability 01/2017 - 12/2000

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2000
14	Phosphotransferases (Kinase)IBA 10/2017 - 04/2000
12	Pharmaceutical PreparationsIBA 01/2021 - 01/2000
11	VaccinesIBA 01/2022 - 01/2001
10	DNA (Deoxyribonucleic Acid)IBA 12/2010 - 01/2000
9	EnzymesIBA 01/2022 - 02/2000
8	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2012
8	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 12/2000
8	Messenger RNA (mRNA)IBA 02/2011 - 01/2000
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2009 - 01/2000
8	Neuregulin-1 (Neuregulin 1)IBA 03/2008 - 01/2000
7	LigandsIBA 01/2019 - 01/2000
7	p21-Activated KinasesIBA 01/2016 - 04/2000
7	histidine-rich proteinsIBA 03/2008 - 01/2000
6	Insulin (Novolin)FDA Link 10/2021 - 06/2007
6	CytokinesIBA 03/2019 - 06/2006
6	Tyrosine (L-Tyrosine)FDA Link 10/2017 - 07/2000
6	Estrogens (Estrogen)FDA Link 01/2017 - 07/2002
6	CalciumIBA 01/2017 - 06/2001
6	AcidsIBA 09/2016 - 10/2000
6	ChromatinIBA 01/2016 - 10/2001
6	Estradiol (Delestrogen)FDA LinkGeneric 07/2005 - 12/2000
5	SteroidsIBA 04/2022 - 07/2005
5	Immunoglobulin G (IgG)IBA 02/2022 - 08/2008
5	AntibodiesIBA 02/2022 - 01/2003
5	Immunoglobulin E (IgE)IBA 03/2019 - 12/2000
5	SuspensionsIBA 01/2019 - 06/2013
5	Biological ProductsIBA 01/2017 - 01/2000
5	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2000
5	Peptides (Polypeptides)IBA 01/2014 - 01/2000
5	SmokeIBA 12/2013 - 09/2001
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2011 - 05/2001
4	Hypoglycemic Agents (Hypoglycemics)IBA 10/2021 - 05/2003
4	AntigensIBA 01/2019 - 07/2001
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2002
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 07/2002
4	AllergensIBA 12/2012 - 01/2006
4	Radioisotopes (Radionuclides)IBA 03/2011 - 12/2000
4	AntioxidantsIBA 08/2009 - 03/2000
4	Calcium OxalateIBA 07/2007 - 03/2002
3	Indicators and Reagents (Reagents)IBA 01/2022 - 06/2010
3	LipidsIBA 03/2021 - 09/2001
3	Protons (Proton)IBA 08/2018 - 09/2001
3	Immunoglobulin M (IgM)IBA 03/2018 - 10/2008
3	Threonine (L-Threonine)FDA Link 10/2017 - 01/2001
3	Epidermal Growth Factor (EGF)IBA 01/2017 - 01/2001

Therapy/Procedure

52	Therapeutics 10/2022 - 03/2000
10	Drug Therapy (Chemotherapy) 10/2022 - 06/2000
9	Radiotherapy 01/2019 - 06/2003
6	Deep Brain Stimulation 12/2004 - 01/2000
5	Length of Stay 04/2022 - 05/2001
4	Transplantation 01/2021 - 09/2001
4	Catheters 01/2014 - 04/2001
3	Lasers (Laser) 02/2022 - 02/2018
3	Neoadjuvant Therapy 12/2021 - 04/2003
3	Surgical Amputation (Amputations) 10/2020 - 03/2000
3	Nephrectomy 11/2018 - 07/2000
3	Contraindications 01/2018 - 07/2000